Del.icio.us
Google
Yahoo MyWeb
Facebook
Cardioxyl Overview
Cardioxyl Pharmaceuticals’ mission is the discovery and development of new
classes of safe and effective therapeutic agents for the treatment of
cardiovascular disease. Cardioxyl's initial program is a novel medication for
the treatment of acute decompensated heart failure.
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 12/2006 | Series A | 14.5M | Unknown |
Products
| Name: | Cardioxyl Drug Program for ADHF |
| Product URL: | http://www.cardioxyl.com/Technology.html |
| Description: | Cardioxyl's first drug program focuses on nitroxyl (HNO) donors and their potential for the intravenous treatment of acute decompensated heart failure (ADHF). |
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
Profile
OpinionsUser Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Overall, are you bullish or bearish on Cardioxyl?
0 votes
0 votes
Vote to see results or
Web Metrics
View All Web Metrics »
| Alexa Rank: | n/a |  |
n/a |
| Yahoo Search Results: | n/a | ||
Cardioxyl on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...
Jobs
by
SimplyHired